{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:55:57Z","timestamp":1768553757963,"version":"3.49.0"},"reference-count":15,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:p>This case series demonstrates a novel clinical phenotype of gait disturbance as an initial symptom in children &amp;lt;3 years old with anti\u2013N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis. Anti-NMDAR encephalitis is one of the most common causes of encephalitis in children, more common than any of the viral encephalitides and the second most common autoimmune cause after acute disseminated encephalomyelitis. Anti-NMDAR encephalitis in children often presents with disrupted speech and sleep patterns followed by progression to motor dysfunction, dyskinesias, and seizures. Because this condition can present initially with vague symptoms, diagnosis and treatment of anti-NMDAR encephalitis are often delayed. Although nearly 40% of all reported patients are &amp;lt;18 years old, few infants and toddlers have been reported with this disease. Four children &amp;lt;3 years old were diagnosed with anti-NMDAR encephalitis at our institution. Interestingly, each child presented initially with the chief concern of gait disturbance. One child presented with unsteady walking and slurred speech, suggestive of cerebellar ataxia, and 3 had inability to bear weight on a unilateral lower extremity, resulting in unsteady gait. Two of these children had seizures at the time of hospital presentation. All developed classic behavioral changes, insomnia, dyskinesias, or decreased speech immediately before or during hospitalization. When seen in the setting of other neurologic abnormalities, gait disturbance should raise the concern for anti-NMDAR encephalitis in young children. The differential diagnosis for gait disturbance in toddlers and key features suggestive of anti-NMDAR encephalitis are reviewed.<\/jats:p>","DOI":"10.1542\/peds.2016-0901","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T09:07:21Z","timestamp":1471338441000},"source":"Crossref","is-referenced-by-count":26,"title":["Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis"],"prefix":"10.1542","volume":"138","author":[{"given":"Anusha K.","family":"Yeshokumar","sequence":"first","affiliation":[{"name":"Division of Pediatric Neurology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Klein","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, and"},{"name":"Department of Pediatrics, The Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin W.","family":"Baranano","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Pardo","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"issue":"7","key":"2021120907173036800_B1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project.","volume":"54","author":"Gable","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2021120907173036800_B2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study.","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2021120907173036800_B3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ana.20614","article-title":"Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma.","volume":"58","author":"Vitaliani","year":"2005","journal-title":"Ann Neurol"},{"issue":"12","key":"2021120907173036800_B4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti\u2013NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"5","key":"2021120907173036800_B5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpneuro0493","article-title":"A patient with encephalitis associated with NMDA receptor antibodies.","volume":"3","author":"Sansing","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"issue":"2","key":"2021120907173036800_B6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti\u2013NMDA receptor encephalitis: an observational cohort study.","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"2","key":"2021120907173036800_B7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pediatrneurol.2013.10.002","article-title":"Anti\u2013N-methyl-D-aspartate receptor\u2013mediated encephalitis in infants and toddlers: case report and review of the literature.","volume":"50","author":"Goldberg","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"1","key":"2021120907173036800_B8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti\u2013N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"issue":"7","key":"2021120907173036800_B9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/000992280304200702","article-title":"Post-infectious acute cerebellar ataxia in children.","volume":"42","author":"Nussinovitch","year":"2003","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"2021120907173036800_B10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3928\/00904481-20140325-13","article-title":"Approach to acute ataxia in childhood: diagnosis and evaluation.","volume":"43","author":"Sivaswamy","year":"2014","journal-title":"Pediatr Ann"},{"issue":"10","key":"2021120907173036800_B11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler"},{"issue":"10","key":"2021120907173036800_B12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1474-4422(08)70216-3","article-title":"Diagnosis and initial management of cerebellar infarction.","volume":"7","author":"Edlow","year":"2008","journal-title":"Lancet Neurol"},{"issue":"6","key":"2021120907173036800_B13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/MOP.0b013e328365ad3f","article-title":"Pediatric Guillain\u2013Barr\u00e9 syndrome.","volume":"25","author":"Ryan","year":"2013","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"2021120907173036800_B14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"issue":"2","key":"2021120907173036800_B15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nic.2012.12.009","article-title":"Anti-NMDA receptor encephalitis.","volume":"23","author":"Jones","year":"2013","journal-title":"Neuroimaging Clin N Am"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-0901\/1095652\/peds_20160901.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-0901\/1095652\/peds_20160901.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T01:51:35Z","timestamp":1639101095000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/138\/3\/e20160901\/52765\/Gait-Disturbance-as-the-Presenting-Symptom-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,9,1]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2016-0901","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]},"article-number":"e20160901"}}